MADALYN UNRUH: Open Payments
NPI 1689000762 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 40 payments from 14 companies in 2025. Trend: 2023 $1,053 · 2024 $886 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $142 |
| PFIZER INC. | 7 | $114 |
| Lilly USA, LLC | 3 | $73 |
| Janssen Biotech, Inc. | 4 | $71 |
| Celltrion USA Inc. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| ABBVIE INC. | 3 | $52 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Gilead Sciences, Inc. | 2 | $43 |
| GENZYME CORPORATION | 1 | $20 |
Products named: ENTYVIO, DUPIXENT, OMVOH, TREMFYA, VELSIPITY, VEGZELMA, ZENPEP, XELJANZ.
Industry payments across KS — which companies pay providers there.
